Northwestern University Human Resources
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men
Phase 1
Withdrawn
- Conditions
- Depressive SymptomsAnxiety Generalized
- Interventions
- Behavioral: Mobile Phone Application
- First Posted Date
- 2014-02-26
- Last Posted Date
- 2017-08-17
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT02072252
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation
Phase 1
Completed
- Conditions
- Type 2 DiabetesComplication of TransplantObesityCardiovascular DiseaseHypertension
- Interventions
- Procedure: Sleeve Gastrectomy
- First Posted Date
- 2014-02-21
- Last Posted Date
- 2015-10-02
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 1
- Registration Number
- NCT02068872
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
SRL (Sirolimus) Withdrawal
Not Applicable
Completed
- Conditions
- Acute Rejection of Liver TransplantEffects of Immunosuppressant Therapy
- Interventions
- First Posted Date
- 2014-02-14
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 21
- Registration Number
- NCT02062944
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
(TAP) Block vs. Systemic Lidocaine: Effects on Recovery
Not Applicable
Withdrawn
- Conditions
- SurgeryPain
- Interventions
- Drug: Systemic lidocaineDrug: TAP BLOCK with ropivacaine
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2019-12-16
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT02053558
Flexibility In Duty Hour Requirements for Surgical Trainees Trial - "the FIRST Trial"
Not Applicable
Completed
- Conditions
- Patient SafetyResident Work Hours
- Interventions
- Behavioral: flexible duty hours
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2017-09-13
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 152
- Registration Number
- NCT02050789
Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
Phase 2
Completed
- Conditions
- Recurrent Adult Soft Tissue SarcomaStage IV Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaAdult Angiosarcoma
- Interventions
- First Posted Date
- 2014-01-29
- Last Posted Date
- 2022-04-25
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 31
- Registration Number
- NCT02048722
- Locations
- 🇺🇸
Sarcoma Oncology Center, Santa Monica, California, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸Washington University-St. Louis, Saint Louis, Missouri, United States
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
Completed
- Conditions
- Bipolar Depression
- First Posted Date
- 2014-01-29
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 91
- Registration Number
- NCT02048995
- Locations
- 🇺🇸
Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States
Discharge Functional Status and Rehospitalization in the Elderly
Completed
- Conditions
- AnxietySocial IsolationDebilityDepression
- First Posted Date
- 2014-01-22
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 300
- Registration Number
- NCT02041585
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx
Phase 1
Completed
- Conditions
- HER2-positive Breast CancerRecurrent Breast CancerStage IV Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer
- Interventions
- Drug: PI3K inhibitor BYL719Biological: ado-trastuzumab emtansineOther: pharmacological studyOther: laboratory biomarker analysis
- First Posted Date
- 2014-01-16
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 17
- Registration Number
- NCT02038010
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
Not Applicable
Completed
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Interventions
- Device: Prostate Artery Embolization
- First Posted Date
- 2014-01-03
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 45
- Registration Number
- NCT02026908
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath